IN 1962 Dr. Paul Dudley White spoke on rheumatic fever when he gave the first T. Duckett Jones Lecture. Since then seven other speakers have dealt with the subject. I feel that there is really nothing I could add, although the pathogenesis of rheumatic heart disease remains unclear. Among the earliest investigators of this dispase was Dr. Jones, who suggested that rheumatic fever represented a peculiar immune response to the streptococcus. In testing this theory, he examined skin hypersensitivity to streptococcal proteins and stated, "a better knowledge of this skin reactivity may be important in determining if an allergic mechanism is responsible for rheumatic fever."' The streptococcal material that he used for skin testing produced a delayed reaction, but this delayed skin reaction was of a peculiar sort. It was transient, not persistent like that of tuberculin hypersensitivity.
This delayed yet transient reaction after injection of a foreign protein in sensitized patients was first called the Jones-Mote reaction.' It has been renamed cutaneous basophil hypersensitivity, because in this reaction there is an accumulation of basophils.2 This is in contrast to tuberculin-type delayed hypersensitivity in which basophils are virtually absent.
During the course of the immunologic processes associated with the Jones-Mote reaction, the basophils discharge vasoactive mediators, such as histamine and serotonin. These chemicals lead to the local instability of the vascular bed at the inflammatory sites of many allergic reactions.2 There is no evidence that the Jones-Mote reaction plays a role in the pathogenesis of rheumatic feveror that it does not! Dr. Jones would be pleased to know that his perplexing skin reaction has now been explained and we know that its mechanisms are important in many allergic diseases.
Geography of Heart Disease I will discuss the geography of heart disease for several reasons. First, infection is clearly a common cause of heart disease, particularly outside the United States. In much of the world, rheumatic heart disease, luetic heart disease, and Chagas' disease outstrip by far the incidence of arteriosclerotic heart disease. I will examine the influence of infection on geography of heart disease in the world.
It is generally agreed that rheumatic heart disease, very common in Europe and America 50-75 years ago, has been replaced in importance by arteriosclerotic heart disease. It is widely accepted that a similar evolution in the etiology of heart disease will occur in the developing world; but I am not so sure. Will there really be a mimicry of our own society in the remainder of the world in the years ahead? Will the geography of the developing world support a version of our own peculiar society, a society that has witnessed the demise of rheumatic heart disease but fueled the current epidemic of arteriosclerotic heart disease? Can we really predict now, with any certainty, the topography of heart disease in the next century? Will rheumatic heart disease, still common in much of the world, disappear there, also, as it has in England and the United States? What are the general conditions of life that have determined this disappearance, and can this benefit be extended around the world? To answer these questions, I shall consider three points.
First, I will examine the changing incidence of acute rheumatic fever in the United States. Second, I will discuss the incidence of rheumatic fever and rheumatic heart disease in the developing countries. Finally, I will review briefly the economic and social trends which, in my judgment, will perpetuate the occurrence of rheumatic heart disease throughout the developing world and into the twenty-first century unless we renew now our commitment to research on rheumatic fever and rheumatic heart disease. We have neither the theoretical nor practical knowledge for launching an attack on this worldwide killer, pitted as we are against intractable forces of geography and the general conditions of life in the world at large, but particularly in Africa and Asia.
Rheumatic Fever in the U.S.
First, I will consider the changing incidence of acute rheumatic fever in the United States. Most investigators agree that there has been a dramatic decrease in incidence of rheumatic fever and a decline in its severity. Bland and Jones noted that severe carditis was more likely to occur in rheumatic fever patients of the 1920s than in patients of the 1950s.3 Figure 1 shows the declining U.S. mortality rate for rheumatic heart disease and the increase in arteriosclerotic heart disease. Dr. Milton Markowitz4 and other previous lecturers have noted that the decrease in the frequency and severity of rheumatic fever began before the discovery and use of penicillin to prevent rheumatic fever. The high mortality rate due to rheumatic fever/rheumatic heart disease early in this century is an extrapolation. There are no national statistical data before 1940 comparable to those published since then. Yet the recollections of cardiologists of those early years deserve attention and support the frequent occurrence of rheumatic heart disease. *3, 4 The influence of socioeconomic factors on the decline in rheumatic fever have been studied. In *The frequency of rheumatic fever and rheumatic heart disease early in this century is suggested by the fact that the majority of Dr. White's early papers dealt with these problems. During World War 1, he performed the first double-blind studies proving conclusively that treatment of rheumatic fever with aspirin did not prevent subsequent development of valvular, progressive rheumatic heart disease.
recognizing the role of these factors in diminishing the occurrence of rheumatic fever before antibiotics, I do not minimize the importance of modern methods of primary and secondary prevention of rheumatic fever methods of prevention that rest on 50 years of innovative bacteriologic and epidemiologic research by Dr. Jones himself and by Lancefield, Rammelkamp, McCarty, Wannamaker, Stollerman and many more. I spent over 20 years in research on streptococci and streptococcal diseases.
However, we still lack a complete explanation for the decline in rheumatic fever. What, for example, was the prior role of poor nutrition in the frequent recurrences of rheumatic fever? Did the poor diets of the Victorian age and of the period before World War I predispose to rheumatic fever, perhaps modulating in a way not yet understood the immunological system and the immune response to streptococcal infections? We now have experimental and clinical evidence that malnutrition does, indeed, have unanticipated influences on immunologic processes. Perhaps recent socioeconomic changes that have supported our abundant life have also been factors in the diminution in the severity and frequency of rheumatic heart disease by blunting the pathologic processes of rheumatism. Figure 1 reveals that the decrease in the death rate due to rheumatic fever since 1900 has been associated with an increase in death rate due to arteriosclerotic heart disease. Paul Dudley White noted in 1971 that '6coronary heart disease was actually much less common" when he graduated from medical school in 1911. He went on to substantiate this impression by citing the first 100 papers in his own bibliography, noting that only two were concerned with coronary heart disease. "Certainly," Dr. White said, "if coronary heart disease had been as common as it is today, I would have been forced to study it and write about it earlier in the century, since I was trying to cover the entire field of cardiology in those early days."5 After 1925, the balance shifted, as he discovered when he returned to his case load and reviewed the charts and autopsies.
It is ironic that the very forces of economic and social change that have given us food, clothing, shelter, leisure and luxury beyond expectation and that seem to have diminished the occurrence of rheumatic heart disease, appear also to have enhanced the occurrence of arteriosclerotic heart disease.
Rheumatic Fever in Developing Countries
Next I will discuss rheumatic fever in the developing countries. In these regions, rheumatic heart disease remains one of the most common causes of heart conditions. 6' 7 Authorities in India recently told me that rheumatic heart disease in their country of 500 million people accounts for 35% of all heart disease.
Clinical data also substantiate the importance of rheumatic heart disease in Africa. In These clinical data are substantiated by autopsy findings. Hutt presented the observations from 4769 autopsies.8 As shown in table 1, 637 had organic heart disease as a primary diagnosis and rheumatic heart disease is as common as hypertensive heart disease. Note especially the frequency of other infections as a cause of heart disease: syphilis, pericarditis and endocarditis. And note, of course, the absence of arteriosclerotic heart disease.
Nevertheless, the frequency of rheumatic fever throughout the world is still clouded. There has been uncertainty, for example, about the clinical picture of streptococcal sore throat and of rheumatic fever in the developing world. Because of this uncertainty the question has been asked whether the Jones criteria are a reliable guide to the diagnosis of acute rheumatic fever in countries in these geographical regions?
Several years ago, we undertook a study in Egypt to examine this question.9 Our first objective was to determine whether the clinical manifestations included Abbreviations: ARF = acute rheumatic fever; RHD = 7.9 rheumatic heart disease.
in the Jones criteria shown in table 2 were a reliable guide to the diagnosis of acute rheumatic fever in a subtropical country such as Egypt. The second objective was to determine if the clinical picture of rheumatic fever in Egypt is similar to that of acute rheumatic fever in temperate countries such as the United States.
Patients referred to us with a diagnosis of suspected rheumatic fever were initially classified by the modified Jones criteria. At this initial screening, streptococcal antibody tests were not used for diagnosis.
The case material which was examined in this study is tabulated in table 3. Two hundred patients had been referred to the clinic of the Rheumatic Fever Project for evaluation. Of these 200 cases, 80 were diagnosed as first-attack rheumatic fever, 45 cases had complete Jones clinical criteria, all had migrating polyarthritis, and nine had carditis. Thirty-five patients probably had rheumatic fever, but they did not fulfill the Jones criteria and are listed as incomplete Jones criteria. Twenty-six cases had rheumatic heart disease with recurrent rheumatic fever. Ninety-four patients could not be classified as having acute rheumatic fever.
Only after the patients had been classified in this way were laboratory tests performed to obtain supporting evidence for a prior streptococcal infection. Table 4 shows the streptococcal antibody data on the 80 patients who had rheumatic fever with either complete Jones criteria or incomplete criteria, and these are contrasted with patients who did not have rheumatic fever. The antibody titers of complete Jones t70% had one or more elevated antibodies. Abbreviation: ARF = acute rheumatic fever.
criteria cases are higher than cases with incomplete criteria; and the antibody titers of both groups are much higher than those of the patients with illnesses other than rheumatic fever. We concluded, therefore, that the clinical Jones criteria can be used in the diagnosis of rheumatic fever in the developing countries.
The Future of Rheumatic Heart Disease The question we must now pose is: Will the pattern of heart disease change in Africa and Asia? Infections have clearly been and are now the predominant influence on the geography of heart disease in these parts of the world, but will this picture change with industrialization of those vast regions of the world? Is our Western style of industrialization and agriculture inevitable? And will this style bring the cardiac hallmark of Western culturearteriosclerotic heart disease and a demise of rheumatic heart disease? This may not be inevitable. For geographic reasons, the social and economic development of the rest of the world is unlikely to follow the same path taken by Europe and America. Global resources are unlikely to sustain for all people a lifestyle that enhances arteriosclerosis and diminishes rheumatic fever. In my view, for much of the globe, geography will continue to favor the infectious origins of heart disease.
The architecture of the twenty-first century is still largely unknown. We can barely perceive the turbulence inherent at the interface between an optimistic and vigorous scientific technology and a desperate Malthusian demographya collision between rising populations and diminishing natural resources.
In a penetrating analysis of the biologic and geographic origins of the new pessimism, entitled the Twenty Ninth Day, Lester Brown emphasizes the biological systems which are the under pinnings of our economic resources. And he dramatically pictures our present predicament by posing a French riddle.
In this riddle, a lily pond contains a single leaf. Each day the number of leaves doublestwo leaves the second day, four the third, eight the fourth, and so on. If the pond is completely full on the thirtieth day, when is it half-full? Answer: on the twenty-ninth day. Brown believes we are living in the twenty-ninth day.
Although United Nations projections show world population continuing to grow until it reaches 10-16 billion, Brown believes this is unrealistic. Humanity and civilization depend on four major biological systems: ocean fisheries, forests, grasslands and croplands. In Brown's analysis, it can be seen that demands at current levels of population and per capita consumption often exceed the long-term carrying capacity of these systems. The author documents the overfishing, the deforestation, the overgrazing, and the soil erosion that are gradually undermining the four major human life support systems.
What can we conclude from these biologic and economic projections about the occurrence of rheumatic heart disease in the next century? I believe that rheumatic heart disease will continue to plague the world as it does now unless we do something. We must begin by resuming research on rheumatic fever.
Indian scientists have asked us to work with them to solve this major health problemrheumatic heart disease. The solutions, of course, are not obvious. The problem is far more complex than the application of Western methods of prevention to the population of India. This is no simple matter of technology transfer. We must reexamine the issues pertaining to the epidemiology, pathogenesis and prevention of rheumatic fever, considering the prevailing geography in each country. When we do that there will emerge new medical opportunities for eliminating this disease, area by area.
Researchers in India, Egypt and elsewhere are experimenting with alternative forms of penicillin prophylaxis. Together with these foreign scientists, we must probe more deeply if we are to find a solution.
In research on rheumatic fever perhaps we should use more fully new advances in microbiology and immunology. While there has been much speculation on the influence of genetic factors in the occurrence of rheumatic fever, there has been no direct support for this notion. There is, therefore, considerable interest in the report of Patarroyo et al. 10 that an association has been found between a particular B cell alloantigen and susceptibility to rheumatic fever. In this study, a novel B cell alloantigen was found at a significantly increased frequency among patients with rheumatic fever. While this provides direct support for the concept that an immunogenetic factor relevant to the pathogenesis of rheumatic fever after a streptococcal infection, the nature of the genetic influence has not been determined. This and other leads must be pursued.
I have one specific suggestion to make that involves this Council and this Heart Association. I ask the Council and the Heart Association to renew rheumatic fever research efforts. You gave this your commitment in the pastand the people beyond our shores need that commitment now. Your outspoken leadership would do much to prod national governments and international agencies to get on with this matter. You can help mobilize opinion so that the World Health Organization (WHO) faces this problem aggressively. You should request that Dr. Mahler foster collaboration between the separate components of WHO that deal with heart disease and infectious diseases; and you should insist on the cooperation of the National Heart, Lung and Blood Institute and the National Institute of Allergy and Infectious Diseases on this worldwide heart problem. And if, in your judgment, we don't cooperate, you should suggest to Dr. Donald Fredrickson, Director of the National Institutes of Health, that he knock our heads together. T. Duckett Jones would have liked that! So let us get on with our research. Let us do something about rheumatic fever and other infections that continue to influence the geography of heart disease in the world today.
